Publications | YHEC - York Health Economics Consortium

A selection of research publications by York Health Economics Consortium.

Click on the titles to read more about the research project. Please note that this is not a comprehensive list of projects completed by YHEC.

2024

Economic Evaluation of the Liverpool Heart Failure Virtual Ward Model

Rasoul D, Chattopadhyay I, Mayer T, West J, Stollar H, Black C, Oguguo C, Kaur R, MacDonald R, Pocock J, Uzdzinska B, Umpleby B, Hex N, Lip GYH, Sankaranarayanan R

November 2024

Cost-Effectiveness Analysis of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Low Risk of Surgical Mortality in Sweden

Nilssona K, James S, Angerås O, Backes J, Bjurstene H, Candolfi P, Götberg M, Hagström H, Malmberg C, Nielsen NE, Sarmah A, Settergren M, Bromilow T

October 2024

Economic Impact Case Study of a Wearable Medical Device for the Diagnosis of Obstructive Sleep Apnoea

Setters J, Paynter J, Hanlon J

October 2024

Uncertainties in Evaluating the Health-Related Quality of Life and Disease Burden of People with Rare Diseases and Their Caregivers in NICE HST Submissions

Looby A, Dymond A, Green W, Wentzel H, Malottki K

October 2024

A Cost-Effectiveness Analysis of RefluxStop Against Relevant Therapeutic Alternatives for Chronic Gastroesophageal Reflux Disease in Sweden

Sam Harper S, Kartha M, Mealing S, Lundell L

September 2024

Literature Review and Meta-Analysis of Natalizumab Therapy for the Treatment of Highly Active Relapsing Remitting Multiple Sclerosis in the ‘Suboptimal Therapy’ Patient Population

Chappell M, Sanderson A, Arun T, Green C, Davies H, Tempest M, Watkins D, Arber M, McCool R

September 2024

Economic Impact of a Vision-Based Patient Monitoring System Across Five NHS Mental Health Trusts

Buckley C, Malcolm R, Hanlon J

September 2024

The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System

Harper S, Kartha M, Mealing S, Pavanello M, Bonavina L

August 2024

A Danish Healthcare-Focused Economic Evaluation of First-Line Cryoballoon Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Paroxysmal Atrial Fibrillation

Hansen ML, Moss JWE, Tønnesen J, Johansen ML, Kuniss M, Ismyrloglou E, Andrade J, Wazni O, Mealing S, Sale A, Afonso D, Bromilow T, Lane E, Chierchia GB

July 2024

Estimation of the Direct Health and Indirect Societal Costs of Diabetes in the UK Using a Cost of Illness Model

Hex N, MacDonald R, Pocock J, Uzdzinska B, Taylor M, Atkin M, Wild SH, Beba H, Jones R

June 2024

Cost-Effectiveness of the RefluxStop Device for Management of Refractory Gastroesophageal Reflux Disease in Switzerland

Harper S, Kartha M, Mealing S, Borbély YM, Zehetner J

June 2024

An Early Economic Evaluation of Kooth, a Web-Based Mental Health Platform for Children and Young People with Emerging Mental Health Needs

Coote L, Kelly L, Graham C, Curtis-Gretton L, Green M, Salhi L, de Ossorno Garcia S, Sefi A, Holmes H

May 2024

Is the Comparator in Your Diagnostic Cost-Effectiveness Model “Standard of Care”? Recommendations from Literature Reviews and Expert Interviews on How to Identify and Operationalise It

Graziadio S, Gregg E, Allen J, Neveux P, Monz BU, Davenport C, Mealing S, Holmes H, Ferrante di Ruffano L

May 2024

The Relationship Between Prescription Rates of Oral Corticosteroids for Respiratory Diseases and Deprivation in England

Barker E, Pocock J, Moss J, Hex N, Rankin J, Hudson R

April 2024

Renal Denervation for Uncontrolled Hypertension: A Systematic Review and Meta-Analysis Examining Multiple Subgroups

Sharp ASP, Sanderson A, Hansell N, Reddish K, Miller P, Moss J, Schmieder R, McCool R

April 2024

Cost-Utility Analysis of TAVI Compared with Surgery in Patients with Severe Aortic Stenosis at Low Risk of Surgical Mortality in the Netherlands

Eerdekens R, Kats S, Grutters JPC, Green M, Shore J, Candolfi P, Oortwijn W, Van Der Harst P, Tonino P

March 2024

Concordance of Randomised Controlled Trials for Artificial Intelligence Interventions with the CONSORT-AI Reporting Guidelines

Martindale APL, Ng B, Ngai V, Kale AU, Ferrante di Ruffano L, Golub RM, Collins GS, Moher D, McCradden MD, Oakden-Rayner L, Rivera SC, Calvert M, Kelly CJ, Lee CS, Yau C, Chan AW, Keane PA, Beam AL, Denniston AK, Liu X

February 2024

Systematic Review and Meta-Analysis of Pharmacological Interventions in Adult-Onset Still’s Disease Highlights the Beneficial Role of Biologic DMARDs

Ruscitti P, McGonagle D, Garcia VC, Rabijns H, Toennessen K, Chappell M, Edwards M, Miller P, Hansell N, Moss J, Graziadio S, Feist E

February 2024

Predictors of Left Ventricular Ejection Fraction in High-Risk Percutaneous Coronary Interventions

Panoulas VF, Escaned J, Hill JM, Barker E, Butler K, Almedhychy A, Tsintzos SI, O’Neill WW

February 2024

Economic Evaluation of First-Line Cryoballoon Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Paroxysmal Atrial Fibrillation from an English National Health Service Perspective

Paisey J, Moss J, Andrade J, Kuniss M, Wazni O, Chierchia GB, Mealing S, Ismyrloglou E, Sale A, Souter M, Kaplon R, Bromilow T, Lane E, Lewis D, Todd D

January 2024

An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population

Moss JWE, Todd D, Grodzicki L, Palazzolo B, Mattock R, Mealing S, Souter M, Brown B, Bromilow T, Lewis D, McCready J, Tayebjee M, Shepherd E, Sasikaran T, Coyle C, Ismyrloglou E, Johnson NA, Kanagaratnam P

January 2024